Blood Vessels News and Research

RSS

JAK inhibitors and tocilizumab elicit better response rates in VEXAS syndrome

New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome compared to other targeted therapies.

7 Nov 2023

New method could enhance the ability to detect and predict anaphylaxis during oral food challenges

Food allergies can quickly turn a casual meal into a life-threatening situation.

7 Nov 2023

Children need to be screened for vision problems as often as adults with sickle cell disease, study suggests

Sickle cell disease is a rare, inherited disorder in which the red blood cells become hard, sticky, and change shape, resembling the farm tool.

6 Nov 2023

Yabing Chen receives NIH grants to advance vascular disease research

Yabing Chen, Ph.D., has been awarded two National Institutes of Health grants totaling more than $5 million to further her research into vascular diseases ranging from hardening of the arteries to dementia.

6 Nov 2023

Two reproductive health conditions associated with increasing cardiovascular disease risk in women

Two reproductive health conditions common in women, polycystic ovary syndrome and dysmenorrhea, are each associated with increasing cardiovascular disease risk, according to two preliminary studies to be presented at the American Heart Association's Scientific Sessions 2023.

6 Nov 2023

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

Comprehensive review unravels the complexities of long COVID, spanning pathophysiology to management strategies, and underscores the need for targeted therapies and early diagnosis.

5 Nov 2023

Tufts researchers explore the science of aging

Anti-wrinkle creams, superfoods that keep you young, dietary supplements that promise improved memory, "immortal" cells that can renew themselves forever-;in our stores and media, claims about aging abound.

2 Nov 2023

LMU medical scientists discover new mechanism of alarmin release

LMU medical scientists have demonstrated that important pro-inflammatory mediators are released into the bloodstream through tiny pores in the cell membrane at a very early stage of the immune response.

2 Nov 2023

Cancer neuroscience: A new frontier in cancer treatment

Cancer cells hijack normal biological processes, allowing them to multiply. For example, tumors spur construction of new blood vessels, building themselves "highways" to supply nutrients.

1 Nov 2023

Researchers harness a combination of lab-grown cells to regenerate damaged heart muscle

Researchers at the University of Wisconsin–Madison and Academia Sinica of Taiwan have harnessed a combination of lab-grown cells to regenerate damaged heart muscle.

31 Oct 2023

A four-stage classification of heart attack based on heart muscle damage

Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released Canadian Cardiovascular Society Classification of Acute Myocardial Infarction (CCS-AMI) appearing in the Canadian Journal of Cardiology, published by Elsevier, presents a four-stage classification of heart attack based on heart muscle damage.

31 Oct 2023

Mechanical thrombectomy found to be effective for high-risk pulmonary embolism

New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

31 Oct 2023

Two-year diabetic eye screening could lead to treatment delays and sight loss

Extending the annual screen to two years for people in England considered at low risk of diabetic eye disease could lead to critical treatment delays and sight loss, according to research led by St George's, University of London and Moorfields Eye Hospital NHS Foundation Trust and involving Kingston University, London researchers and academics.

31 Oct 2023

Scientists identify mechanism of alcohol withdrawal headaches

About 283 million people worldwide suffer from alcohol use disorder, a debilitating health challenge for which limited therapeutic options are available. The cost to society is estimated at greater than $2 trillion annually.

30 Oct 2023

New ERC-funded research project aims to develop targeted treatments for chronic wounds and cancer

the Freiburg University Medical Center and member of the Medical Faculty at the University of Freiburg, has received a European Research Council (ERC) Starting Grant from the European Commission.

27 Oct 2023

Treatment in ambulance-based mobile stroke unit increases the likelihood of averting strokes

Receiving a clot-busting drug in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, according to researchers at Weill Cornell Medicine, NewYork-Presbyterian, UTHealth Houston, Memorial Hermann-Texas Medical Center and five other medical centers across the United States.

26 Oct 2023

Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

Extending the annual screen by a year for people in England considered to be at low risk of diabetic eye disease (diabetic retinopathy) could risk critical treatment delays and/or sight loss, suggests a large, real world data study, published online in the British Journal of Ophthalmology.

25 Oct 2023

New study provides insights into the safety of novel therapies for pulmonary embolism

A large, modern real-world analysis published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), provides vital insights into the safety of novel therapies including ultrasound-assisted catheter-directed thrombolysis (USCDT) and mechanical thrombectomy (MT) that have been developed to address the increased morbidity and mortality of elevated risk pulmonary embolism (PE). Findings were presented today at TCT 2023.

25 Oct 2023

Dementia and cholesterol: investigating links and impacts of hormone replacement therapy

The relationships between hormone replacement therapy (HRT), serum cholesterol levels, and dementia incidence.

25 Oct 2023

Engineered bacteria could offer new treatment for hypertension

Scientists at The University of Toledo have proven that engineered bacteria can lower blood pressure, a finding that opens new doors in the pursuit of harnessing our body's own microbiome to treat hypertension.

24 Oct 2023

Blood Vessels News and Research

JAK inhibitors and tocilizumab elicit better response rates in VEXAS syndrome

New method could enhance the ability to detect and predict anaphylaxis during oral food challenges

Children need to be screened for vision problems as often as adults with sickle cell disease, study suggests

Yabing Chen receives NIH grants to advance vascular disease research

Two reproductive health conditions associated with increasing cardiovascular disease risk in women

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

Tufts researchers explore the science of aging

LMU medical scientists discover new mechanism of alarmin release

Cancer neuroscience: A new frontier in cancer treatment

Researchers harness a combination of lab-grown cells to regenerate damaged heart muscle

A four-stage classification of heart attack based on heart muscle damage

Mechanical thrombectomy found to be effective for high-risk pulmonary embolism

Two-year diabetic eye screening could lead to treatment delays and sight loss

Scientists identify mechanism of alcohol withdrawal headaches

New ERC-funded research project aims to develop targeted treatments for chronic wounds and cancer

Treatment in ambulance-based mobile stroke unit increases the likelihood of averting strokes

Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

New study provides insights into the safety of novel therapies for pulmonary embolism

Dementia and cholesterol: investigating links and impacts of hormone replacement therapy

Engineered bacteria could offer new treatment for hypertension

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News